Founded by Dr. Krishnamurthy Natarajan and Dr. ParuI Ganju, Ahammune Biosciences boasts of a highly experienced and skilled founding team. The team brings together both scientific discovery and development expertise in the dermatology arena.
Dr. M.K. Bhan is a pediatrician and clinical scientist who is known for developing Rota Viral Vaccine in collaboration with Bharat Biotech International. He is a former secretary, Department of Biotechnology (DBT), Government of India and a Padma Bhushan awardee. Dr. Bhan is involved with policy formulation role as: Chairman, WHO Task Force on child health research, Member, Board of Directors, International Vaccine Institute, Korea, Chairman, National Task Force on micronutrient policy, Member, Technical Advisory Group, World Health Organization, Member, NIH Task Force on Rotavirus Vaccines, Chairman, Maternal and Child Health Research, Indian Council of Medical Research, Chairman, Scientific Advisory Committee, National Institute of Nutrition, India, and is a member of the Jury for nearly all major national science awards in India. Dr. Bhan has played a leadership role in promoting primary health care for children in rural India during the last two decades. His main endeavor has been to bring fruits of science and technology to national programs for children. He has provided advocacy and leadership to many programs in India including promotion of oral rehydration therapy, micronutrient supplementation, introduction of new vaccines and greater coverage with existing ones.
Dr. Padmanabhan Balaram is an eminent scientist and former director of prestigious Indian Institute of Sciences (IISc), India. He is a recipient of the recipient of honorary Padma Shri and Padma Bhushan award as well as the TWAS Prize in 1994. He also received INSA Medal for Young Scientist, UGC Career Award, UGC National Lecturer, SS Bhatnagar Award, Alumni Award for Excellence in Research by IISc, DAE-CV Raman Lecturer, GD Birla Award. He completed his Ph.D. from Carnegie Mellon University and postdoctoral work at Harvard University with Nobel laureate Robert Burns Woodward. He later joined IISc as faculty in Molecular Biophysics Unit. Dr. Balaram has authored more than 500 research papers and is a fellow of the Indian National Science Academy. He was the editor of the journal Current Science till June 2013. Dr. Balaram is also associated with Ahammune Biosciences Private Limited.
Dr. Natarajan is an Associate Professor at Jawaharlal Nehru University (JNU), New Delhi. He is also a Visiting Scientist at Stowers Institute for Medical Research, Kansas. The broad area of his research is to dissect the mechanisms and paradigms of gene regulatory networks in eukaryotes. He has started a new program for studying transcriptional regulatory networks that control melanogenesis-hyper-pigmentation and hypo-pigmentation using B16 mouse melanoma cell lines as a model. He is an Elected Fellow of National Academy of Sciences, Allahabad, and has several publications in leading journals to his credit. Dr. Natarajan obtained his Ph.D. from JNU and carried out ground-breaking work during his post-doctoral research at the National Institutes of Health, USA and in his own laboratory at JNU.
Dr. Satyajit Rath is a doyen of immunology and is currently associated with Agharkar Research Institute (ARI) and Indian Institute of Science Education and Research (IISER), India. He worked at National Institute of Immunology (NII), New Delhi. He completed his MD in pathology from University of Mumbai, India and postdoctoral work at Haffkine Institute, India; London School of Hygiene and Tropical Medicine, London, UK; Brandeis University, Waltham, USA and Yale University School of Medicine, New Haven, USA. Dr. Rath’s research interests focus on the molecular dissection of the physiological controls governing the generation and activation of T and B lymphocytes as well as cells of the myeloid lineage, using both genetic and pharmacological tools. He has written an extensive number of research papers and also writes extensively on the issues related to the policies of national science and technology. He is a member of the advisory/management board of NCBS, InStem, ILS and Curadev.
Gautham Nadig is an entrepreneur, with interests in developing and commercializing new technologies in life sciences. His current focus is in soil-less, pesticide free agricultural production and a few frontier areas of healthcare including regenerative medicine, Next Generation Sequencing based diagnostics and universal influenza vaccines. In 2001, Dr. Nadig co-founded Metahelix Life Sciences Limited (now a TATA Enterprise) and was responsible for building the product development capabilities, R&D and led several rounds of venture financing of the business. In 2015, Metahelix was sold to Rallis India Limited (a subsidiary of Tata Chemicals Limited). Metahelix is now a leading technology led seeds business in India and active businesses in S.E. Asia. Dr. Nadig serves as an advisor to Sri Research For Tissue Engineering, a regenerative medicine technology developer that has developed new biomaterials and cell therapies for chronic ulcers, Urethral strictures, Stress Urinary Incontinence etc. His recent initiatives are in the area of soil-less cultivation & urban farming (Yugat Farming Technologies), NGS diagnostics (Arkin), universal influenza vaccines (Mynvax) where he has made investments and is responsible for building technology and business. Dr. Nadig graduated with a Masters degree in Physics from Bangalore University and a Ph.D. from the division of Biological Sciences, Indian Institute of Science, Bangalore. He subsequently did a post-doctoral stint at the Pennsylvania State University, USA following which he was a Senior Scientist at Monsanto Research Centre, India and a consultant to the Monsanto Company in the US.
Dr. Ganju co-founded the Company and serves as the Executive Director. She is responsible for technology development and business activities at Ahammune. After completing her Ph.D. in Skin Biology from National Institute of Immunology, Delhi, she was a DST-Inspire Faculty at CSIR-Institute of Genomics and Integrative Biology (CSIR-IGIB). She has extensive experience in the area of dermatology and her major research focus was to understand regulatory mechanisms underlying melanogenesis, the perturbations of which result in complex disorders like Vitiligo. She has published her research in leading international journals like Proceedings of National Academy of Science and Nature Chemical Biology and has filed for multiple patents.